Jiangsu (SH:688426)2023-10-30 16:00Financial Performance - The company's operating revenue for Q3 2023 was ¥29,896,120.36, a decrease of 77.42% compared to the same period last year[5] - The net profit attributable to shareholders for Q3 2023 was -¥25,672,728.77, reflecting a decline of 156.81% year-over-year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses for Q3 2023 was -¥33,659,305.24, down 178.74% from the previous year[5] - The cash flow from operating activities for Q3 2023 was -¥20,797,653.36, a decrease of 133.74% compared to the same period last year[6] - The basic earnings per share for Q3 2023 was -¥0.26, a decline of 140.00% year-over-year[6] - The company experienced a significant decline in sales revenue due to market conditions, impacting overall financial performance[10] - The net profit for the third quarter of 2023 was a loss of ¥30,043,142.29, compared to a profit of ¥149,979,642.03 in the same quarter of 2022, marking a substantial decline[21] - The company reported a basic earnings per share of -¥0.36 for the third quarter of 2023, down from ¥2.08 in the same quarter of 2022[22] Research and Development - Total R&D investment for Q3 2023 was ¥21,598,355.30, an increase of 23.73% compared to the same period last year[6] - R&D investment accounted for 72.24% of operating revenue in Q3 2023, an increase of 59.05 percentage points year-over-year[6] - Research and development expenses for the first three quarters of 2023 totaled ¥63,413,502.91, an increase from ¥45,943,935.21 in 2022, representing a growth of about 38%[19] Assets and Liabilities - Total assets at the end of Q3 2023 were ¥1,871,610,163.74, a decrease of 4.02% from the end of the previous year[6] - Total current assets as of September 30, 2023, amount to ¥1,404,061,396.38, a decrease from ¥1,626,664,083.19 at the end of 2022[15] - Total assets as of September 30, 2023, are ¥1,871,610,163.74, down from ¥1,950,077,684.51[16] - Total non-current assets increased to ¥467,548,767.36 from ¥323,413,601.32[16] - The total liabilities as of the end of the third quarter of 2023 were ¥142,659,090.17, down from ¥158,416,801.31 in the previous year, indicating a decrease of approximately 9.9%[19] - The total equity attributable to shareholders was ¥1,704,033,389.43, a decrease from ¥1,780,346,411.28 in the previous year, reflecting a decline of about 4.3%[19] - The company reported a deferred income tax liability of ¥4,680,540.34, an increase from ¥3,919,586.79 in the previous year, indicating a rise of approximately 19.5%[19] Shareholder Information - Total number of common shareholders at the end of the reporting period is 4,342[13] - The largest shareholder, Beijing Kangwei Century Biotechnology Co., Ltd., holds 50,400,000 shares, accounting for 44.91% of total shares[13] - The company has a total of 50,400,000 shares held by the largest shareholder, which is fully pledged[13] - The company reported a total of 21,600,000 shares held by Taizhou Kangwei Co-Creation Enterprise Management Consulting Partnership, accounting for 19.25%[13] Cash Flow - Cash generated from operating activities for the first three quarters of 2023 was ¥174,575,802.05, a decrease from ¥344,813,000.49 in the same period of 2022, reflecting a decline of approximately 49.3%[23] - Net cash inflow from operating activities was -$19,087,160.89, a significant decrease compared to $109,543,654.28 in the previous year[24] - Total cash inflow from investment activities reached $1,557,454,748.57, up from $647,757,481.60 year-over-year[24] - Cash outflow from investment activities totaled $2,144,551,422.42, compared to $772,176,670.81 in the same period last year[24] - Net cash flow from financing activities was -$50,091,395.07, a decline from -$7,467,497.14 in the previous year[25] - The company's cash and cash equivalents at the end of the period were $376,685,889.28, down from $107,692,246.23 year-over-year[25] - The total cash outflow for operating activities was $207,338,119.29, compared to $261,461,566.95 in the previous year[24] - The company distributed dividends and interest payments totaling $50,623,942.81 during the quarter[25] - The cash flow from operating activities was significantly impacted by a decrease in cash inflow from operating activities, which totaled $188,250,958.40[24] - The company reported a foreign exchange impact on cash and cash equivalents of $1,426,673.57, compared to $2,216,836.72 in the previous year[25] Operating Costs - Total operating revenue for the first three quarters of 2023 was ¥151,454,595.08, a significant decrease from ¥397,953,304.13 in the same period of 2022, representing a decline of approximately 62%[19] - Total operating costs for the first three quarters of 2023 were ¥197,112,229.36, down from ¥220,210,884.02 in 2022, indicating a reduction of about 10.5%[19] - The company experienced a significant increase in sales expenses, which rose to ¥53,348,689.28 in the first three quarters of 2023, compared to ¥41,312,973.18 in the same period of 2022, representing an increase of about 29.2%[19]